Retraction--"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial : The Lancet
Links shared publicly online about this topic.
- 1,680total visits
Retraction--"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial : The Lancet
Retraction--"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. By - The Ed...
View full resource at thelancet.com
Tags: Kidney Health, Urinary System, Kidney Disease, Disease and Condition, Nephrology, disease
Most Recently Shared on October 13, 2009 at 3:45 pm By:
Lancet retracts COOPERATE trial of ARB+ACEI in nondiabetic renal disease after institutional investigation: http://bit.ly/4t0zxN
Advertisement
